India Boosts Pharma-MedTech Innovation with PRIP Workshop

13 Mar 2025 CW Team

The workshop focused on strengthening India’s innovation ecosystem in pharmaceuticals and medical technology. Shri Amit Agrawal highlighted the sector's rapid growth, noting the rising global share of advanced technologies like antibody-drug conjugates and gene therapy — projected to reach 20% of the top-100 drugs by value by 2030. He also pointed to the remarkable tenfold increase in Indian healthcare and life sciences startups, from 900 in 2020 to over 10,000 in 2024.

The PRIP scheme aims to build on this momentum with support from initiatives like CSIR’s INTENT for clinical trials, ICMR’s MedTech Mitra and Patent Mitra, and funding programs like DST’s Quantum Computing Mission and MeitY’s TIDE 2.0 and SAMRIDH. Leaders from DST, MeitY, DHR, and CSIR stressed the importance of digital health, AI, data-driven technologies, and industry-academia collaboration in driving innovation and commercialisation of research.

The workshop hosted over 100 participants from top scientific institutions, including NIPERs, IITs, CSIR labs, and government bodies, with discussions on emerging pharmaceutical and MedTech trends and strategies to transform research into market-ready products. Participants were invited to submit suggestions via the Expression of Interest (EoI) form on the Department of Pharmaceuticals’ website, open until April 7, 2025.

(PIB)

The Department of Pharmaceuticals, under the Ministry of Chemicals and Fertilisers, Government of India, held a workshop on the Promotion of Research and Innovation in the Pharma-MedTech Sector (PRIP) Scheme on March 12, 2025. Senior officials from key government departments participated, including Shri Amit Agrawal, Secretary, Department of Pharmaceuticals; Prof. Abhay Karandikar, Secretary, Department of Science and Technology (DST); Shri S. Krishnan, Secretary, Ministry of Electronics and Information Technology (MeitY); Dr. N. Kalaiselvi, Secretary, Department of Scientific and Industrial Research (DSIR) and Director General of CSIR; and Dr. Rajiv Bahl, Secretary, Department of Health Research (DHR) and DG, ICMR.The workshop focused on strengthening India’s innovation ecosystem in pharmaceuticals and medical technology. Shri Amit Agrawal highlighted the sector's rapid growth, noting the rising global share of advanced technologies like antibody-drug conjugates and gene therapy — projected to reach 20% of the top-100 drugs by value by 2030. He also pointed to the remarkable tenfold increase in Indian healthcare and life sciences startups, from 900 in 2020 to over 10,000 in 2024.The PRIP scheme aims to build on this momentum with support from initiatives like CSIR’s INTENT for clinical trials, ICMR’s MedTech Mitra and Patent Mitra, and funding programs like DST’s Quantum Computing Mission and MeitY’s TIDE 2.0 and SAMRIDH. Leaders from DST, MeitY, DHR, and CSIR stressed the importance of digital health, AI, data-driven technologies, and industry-academia collaboration in driving innovation and commercialisation of research.The workshop hosted over 100 participants from top scientific institutions, including NIPERs, IITs, CSIR labs, and government bodies, with discussions on emerging pharmaceutical and MedTech trends and strategies to transform research into market-ready products. Participants were invited to submit suggestions via the Expression of Interest (EoI) form on the Department of Pharmaceuticals’ website, open until April 7, 2025.(PIB)

Real Estate

02 Apr 2026

Indian real estate attracts USD 1.4 bn institutional investments in Q1 2026: Vestian

Institutional investments in India’s real estate sector touched USD 1.4 billion in Q1 2026, marking the highest first-quarter inflow since 2022, according to Vestian. While investments fell 62 per cent quarter-on-quarter due to an exceptionally high base in the previous quarter, they rose 74 per cent compared to the same period last year, reflecting sustained investor confidence despite rising geopolitical and macroeconomic challenges.Commercial real estate remained the key driver of investment activity during the quarter, accounting for 80 per cent of total inflows, sharply higher than 38 p..

Infrastructure Transport

02 Apr 2026

VECV crosses 1 lakh annual vehicle sales milestone in FY26

VE Commercial Vehicles (VECV), a joint venture between Volvo Group and Eicher Motors, has surpassed the 1 lakh annual sales mark in FY 2025–26, recording its highest-ever commercial vehicle sales performance. The company said it sold more than 100,000 vehicles during the year, marking a major milestone aligned with the original vision of the Volvo–Eicher joint venture.The strong performance was supported by demand across categories. Light and Medium Duty (LMD) trucks contributed 47,789 units, accounting for 46.1 per cent of total sales. Heavy Duty (HD) trucks recorded 26,867 units (25.9 pe..

Technology

02 Apr 2026

Rodic Digital & Advisory partners SatSure to deploy EO intelligence in public sector

Rodic Digital & Advisory (RDA), the strategic advisory and digital transformation arm of Rodic Consultants, has signed a strategic cooperation Memorandum of Understanding (MoU) with SatSure to jointly pursue opportunities in India’s public sector. The collaboration aims to integrate high-resolution Earth Observation (EO) data and geospatial AI into government workflows to strengthen monitoring, compliance, and operational decision-making across key sectors.The partnership combines SatSure’s Earth intelligence capabilities with RDA’s expertise in government digital transformation and ..